Department of Nephrology, Lund University, Lund, Sweden.
Am J Physiol Renal Physiol. 2013 Aug 1;305(3):F237-43. doi: 10.1152/ajprenal.00154.2013. Epub 2013 May 8.
Systemic infusions of ANG II rapidly induce large, dynamic increases in the permeability of the glomerular filtration barrier (GFB) in rats. After binding to its receptor(s), ANG II generates reactive oxygen species (ROS) and produces Ca²⁺ influx into cells, leading to activation of a plethora of signaling cascades, including, e.g., calcineurin and small GTPases, such as Rac-1 and RhoA. In the present study we sought to interact with some of these cascades to test potential novel antiproteinuric agents. In anesthetized Wistar rats, the left urether was cannulated for urine collection, and blood access was achieved. Rats were infused with ANG II (16 ng·kg⁻¹·min⁻¹) alone, or together with the ROS scavengers tempol or dimethylthiourea (DMTU) or the D-vitamin analog paracalcitol, the RhoA-kinase inhibitor Y-27632, the Rac-1 inhibitor NSC-23766, or the calcineurin inhibitor tacrolimus. FITC-Ficoll-70/400 (mol.radius 10-80 Å) and ⁵¹Cr-EDTA were infused throughout the experiment. Plasma and urine samples were taken during baseline and at 5 and 15 min after the start of the infusions and analyzed by high-performance size-exclusion chromatography for determination of glomerular sieving coefficients (θ) for Ficoll10-80Å. ANG II infusion into rats caused marked increases in glomerular permeability to large Ficoll molecules (Ficoll50-80Å), which were abrogated by the ROS scavenger tempol and partly by DMTU. Paracalcitol, RhoA, and Rac-1 inhibition, and, to some extent tacrolimus, but not prostacyclin, could also inhibit the glomerular permeability actions of ANG II. Our data suggest that cellular ROS generation and active Ca²⁺ signaling are involved in ANG II-induced increases in glomerular permeability.
血管紧张素 II(ANG II)全身输注可迅速引起大鼠肾小球滤过屏障(GFB)通透性的大幅、动态增加。ANG II 与其受体结合后会产生活性氧(ROS)并导致细胞内钙离子内流,从而激活大量信号级联反应,包括钙调神经磷酸酶和小 GTP 酶,如 Rac-1 和 RhoA。在本研究中,我们试图干预其中一些级联反应,以测试潜在的新型抗蛋白尿药物。在麻醉的 Wistar 大鼠中,左侧输尿管插管用于尿液收集,并建立血液通路。大鼠输注 ANG II(16ng·kg⁻¹·min⁻¹),或与 ROS 清除剂 Tempo 或二甲基硫脲(DMTU)或 D 型维生素类似物帕立骨化醇、RhoA-激酶抑制剂 Y-27632、Rac-1 抑制剂 NSC-23766 或钙调神经磷酸酶抑制剂他克莫司联合输注。实验过程中持续输注 FITC-Ficoll-70/400(摩尔半径 10-80Å)和 ⁵¹Cr-EDTA。在基线和输注开始后 5 和 15 分钟采集血浆和尿液样本,并通过高效尺寸排阻色谱法分析以确定 Ficoll10-80Å 的肾小球筛系数(θ)。ANG II 输注到大鼠体内可显著增加肾小球对大 Ficoll 分子(Ficoll50-80Å)的通透性,该作用可被 ROS 清除剂 Tempo 部分阻断,也可被 DMTU 部分阻断。帕立骨化醇、RhoA 和 Rac-1 抑制以及在一定程度上他克莫司,但不是前列环素,也可抑制 ANG II 引起的肾小球通透性作用。我们的数据表明,细胞内 ROS 生成和活性 Ca²⁺信号参与了 ANG II 诱导的肾小球通透性增加。